The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
批准号:
10035157
负责人:
Shibani Pati
金额:
$40.38万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-05 至 2024-06-30
关键词:
Adherens JunctionAgeAlpha GranuleAngiopoietin-2AntibodiesBiologicalBiological AssayBloodBlood - brain barrier anatomyBlood CirculationBlood PlateletsBlood VesselsBrainBrain InjuriesCause of DeathCell CommunicationCerebral EdemaCoagulation ProcessCytoskeletonDataEndothelial CellsEndotheliumFunctional disorderGlycocalyxGoalsGrowth FactorHDAC6 geneHemorrhageHemostatic functionHippocampus (Brain)HistonesImmune systemIn VitroIncubatorsIndividualInflammationInjuryIntracranial HemorrhagesInvestigationLesionMolecularMorphologyMusNeurocognitiveNeurocognitive DeficitOrgan failureOutcomePathway interactionsPatientsPermeabilityPlatelet TransfusionRegulationRiskRodent ModelRoleScanningSignal PathwaySignal TransductionStructureTIE-2 ReceptorTemperatureTestingTherapeuticTherapeutic EffectTherapeutic InterventionTransmission Electron MicroscopyTraumaTrauma patientTraumatic Brain InjuryTraumatic injuryVascular Endothelial CellVascular EndotheliumVascular Permeabilitiesantibody inhibitorblood productblood-brain barrier permeabilizationcadherin 5comparison groupcremaster musclecytokinedesignexperimental studyimprovedimproved outcomein vivoinhibitor/antagonistintravital imagingintravital microscopymortalitymouse modelneuroinflammationneuron lossneuroprotectionnovel therapeuticsplatelet storagepreservationpreventprotective effectsevere injuryvascular endothelial cadherin-2vascular endothelium permeabilityvascular injury
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Stability in
Trauma
Trauma is the leading cause of death world-wide in individuals between the ages of 1-44, with
traumatic brain injury (TBI) being the number one cause of death after trauma. Platelet transfusion
and balanced ratios of blood products have been shown to increase survival in severely injured
bleeding trauma patients. In the current US blood-banking practice, platelets (Plts) are stored in
incubators at 22°C for up to 5 days. Storage of Plts at 22°C for 5 days is associated with a storage
lesion, increased infectious risk, and an overall decline in hemostatic function. 4°C storage of Plts
has been proposed as an equivalent and in some cases superior alternative to 22 °C storage.
Therapeutically, in addition to their critical role in hemostasis, Plts are known to safeguard the
integrity of the vascular endothelium. Vascular instability is a hallmark effect of traumatic
injury leading to vascular permeability, inflammation, coagulation disturbances and end organ
failure. In TBI, intracranial hemorrhage (ICH) and cerebral edema are the leading causes of
mortality, which are potentially addressable by Plt transfusion. Our previous data demonstrate
that 4°C Plts regulate vascular stability and inhibit endothelial cell (EC) permeability similar to
22°C Plts. This proposal will aim to elucidate the therapeutic effects of platelets and cold stored
(4oC) platelets on vascular stability in traumatic brain injury (TBI) with the thought that platelets
can be used as a first line therapeutic intervention in TBI to decrease cerebral edema, ICH,
neuroinflammation and improve outcomes in TBI patients. Aim 1 is a mechanistic aim designed
to investigate the structural, molecular and cellular signaling effects of 4°C storage on Plts and
on Plt-endothelial cell interactions and coagulation. Inhibitors of relevant Plt and EC signaling
pathways will be utilized to tease apart what pathways are relevant to Plt effects on endothelial
permeability. Aim 2 is designed to provide a deeper understanding of the effects of 4°C Plts on
the vascular endothelium by using state of the art intravital imaging in the cremaster muscle and
brain, to visualize the effects of 4°C Plts on vascular permeability, clot formation and preservation
of the endothelial glycocalyx. Aim 3 is designed to test out our primary hypothesis that 4°C Plts
can be used to regulate vascular stability in TBI hence improving hemostasis, decreasing
neuroinflammation and neuronal cell loss. In this revised proposal we have demonstrated our
full capabilitiy to execute the proposed studies and have refined our experiments to successfully
answer the questions posed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
-
批准号:10438660
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Shibani Pati
-
依托单位:
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
-
批准号:10229535
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Shibani Pati
-
依托单位:
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
-
批准号:10652299
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Shibani Pati
-
依托单位:
The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in Trauma
-
批准号:10909765
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Shibani Pati
-
依托单位:
Modulation of Pulmonary Vascular Permeability and Inflammation by Mesenchymal Stem Cells (MSCs) in Hemorrhagic Shock
-
批准号:9144825
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2015
-
负责人:Shibani Pati
-
依托单位:
Modulation of Pulmonary Vascular Permeability and Inflammation by Mesenchymal Stem Cells (MSCs) in Hemorrhagic Shock
-
批准号:9030393
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2015
-
负责人:Shibani Pati
-
依托单位:
Modulation of Pulmonary Vascular Permeability and Inflammation by Mesenchymal Stem Cells (MSCs) in Hemorrhagic Shock
-
批准号:9528842
-
项目类别:
-
资助金额:$33.38万
-
财政年份:2015
-
负责人:Shibani Pati
-
依托单位:
Systemic Effects of Bone Marrow-Derived MSCs on Vascular Stability
-
批准号:8111616
-
项目类别:
-
资助金额:$10.59万
-
财政年份:2011
-
负责人:Shibani Pati
-
依托单位:
Systemic Effects of Bone Marrow-Derived MSCs on Vascular Stability
-
批准号:8312468
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2011
-
负责人:Shibani Pati
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: